Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials

Details for Australian Patent Application No. 2011224710 (hide)

Owner Merck Sharp & Dohme Corp. Merck Canada Inc.

Inventors Gallant, Michel; Villeneuve, Karine; Beaulieu, Patrick; Robichaud, Joel; Juteau, Helene; Gareau, Yves; Waddell, Sherman T.; Kevin, Nancy; Gu, Xin; Huber, Joann; Salvatore Jr., Michael J.; Wilson, Kenneth; Smith, Scott K.; Zink, Deborah

Agent Spruson & Ferguson

Pub. Number AU-A-2011224710

PCT Pub. Number WO2011/112441

Priority 61/312,058 09.03.10 US

Filing date 4 March 2011

Wipo publication date 15 September 2011

International Classifications

A61K 38/14 Medicinal preparations containing peptides - Peptides containing saccharide radicals

A61K 38/00 Medicinal preparations containing peptides

A61K 38/12 Medicinal preparations containing peptides - Cyclic peptides

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/112441 Priority application(s): WO2011/112441

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224714-Interlocking reverse hip and revision prosthesis

2011224702-Suture packages providing unconstrained dispensing of sutures and methods therefor